Skip to content

Comparison of Kamdudha Rasa and Eladi Churna in Managing Hyperacidity

Evaluation of comparative efficacy of Kamdudha Rasa Pratham Versus Eladi Churna in the management of Urdhwag Amlapitta (GERD) - A Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093900
Enrollment
160
Registered
2025-08-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Sponsors

Rahul Suresh Nathwani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients fulfilling the diagnostic criteria which are based on clinical signs and symptoms of Urdhwag Amlapitta Patients willing for treatment with informed consent

Exclusion criteria

Exclusion criteria: Patients not willing for the enrollment in the clinical trial Known cases of DM HTN CRF CANCER Any other addictions like chronic alcoholism induced hyperacidity

Design outcomes

Primary

MeasureTime frame
Releving the signs and symtpoms of Amalpitta GERD with as simple and easy interventional medicine Kamdudha Rasa pratham.Timepoint: within one week

Secondary

MeasureTime frame
Founding Releving Amalpitta GERD with as simple and easy available interventional medicine Kamdudha Rasa pratham.Timepoint: One year

Countries

India

Contacts

Public ContactRahul Suresh Nathwani

Research institution and hospital

bhushan.mhaiskar@dmiher.edu.in8983010655

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026